Pre- and Post-Progression Relapses Impact Disability in Progressive MSOctober 7, 2013Multiple Sclerosis
Anti-Lipid Oligoclonal IgM Bands Contribute to PML Risk StratificationOctober 7, 2013Multiple Sclerosis
Comparing Relapse Rates Among Patients With MS Who Switch From Interferon to Fingolimod or Glatiramer AcetateOctober 4, 2013Multiple Sclerosis
Regulation May Be Impaired in Patients With Secondary Progressive MSSeptember 30, 2013Multiple Sclerosis
Brain Atrophy and Lesion Load Predict Long-Term Disability in Multiple SclerosisSeptember 30, 2013Multiple Sclerosis
FDA Investigates Case of PML in Patient With MS Taking FingolimodSeptember 30, 2013Multiple Sclerosis
Investigating the Links Between MS Drugs, Autoimmune Disease, and Disease ProgressionAugust 29, 2013Multiple Sclerosis
New and Noteworthy Information—September 2013August 29, 2013Alzheimer's & CognitionEpilepsy & SeizuresPainHeadache & MigraineMultiple SclerosisStroke
Recommendations Outline How to Improve Dimethyl Fumarate Tolerability in MSAugust 2, 2013Multiple Sclerosis
New and Noteworthy Information—August 2013August 2, 2013Alzheimer's & CognitionStrokeEpilepsy & SeizuresMultiple Sclerosis
